Design and Synthesis of 1,2-Bis(hydroxymethyl)pyrrolo[2,1-a]phthalazine Hybrids as Potent Anticancer Agents that Inhibit Angiogenesis and Induce DNA Interstrand Cross-links
Authors:
- Sue-Ming ChangSCSue-Ming Chang
- Vicky JainVJVicky Jain
- Tai-Lin ChenTCTai-Lin Chen
- Anilkumar S. PatelAPAnilkumar S. Patel
- Hima Bindu PiduguHPHima Bindu Pidugu
- Yi-Wen LinYLYi-Wen Lin
- Ming-Hsi WuMWMing-Hsi Wu
- Jiao-Ren HuangJHJiao-Ren Huang
- Han-Chung WuHWHan-Chung Wu
- Tsann-Long SuTSTsann-Long Su
- Te-Chang LeeTLTe-Chang Lee
- 18 February 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 62 (5) , 2404-2418
Abstract
Hybrid molecules are composed of two pharmacophores with different biological activities. Here, we conjugated phthalazine moieties (anti-angiogenetic pharmacophore) and bis(hydroxymethyl)pyrrole moieties (DNA crosslinking agent) to form a series of bis(hydroxymethyl)pyrrolo[2,1-a]phthalazine hybrids. These conjugates were cytotoxic to a variety of cancer cell lines by inducing DNA damage, arresting cell cycle progression at the G2/M phase, triggering apoptosis and inhibiting vascular endothelial growth factor receptor 2 (VEGFR-2) in endothelial cells. Among them, compound 29d encapsulated in a liposomal formulation (e.g., 29dL) significantly suppressed the growth of small cell lung cancer cell (H526) xenografts in mice. Based on immunohistochemical staining, the tumor xenografts in mice treated with 29dL showed time-dependent decreases in the intensity of CD31, a marker of blood vessels, whereas the intensity of γ-H2AX, a marker of DNA damage, increased. The present data revealed that the conjugation of anti-angiogenic and DNA-damaging agents can generate potential hybrid agents for cancer treatment.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 104-2325-B-001-001, MOST 105-2325-B-001-001, MOST 107-2320-B-001-008, MOST 103-2325-B-001-018)
- Academia Sinica (AS-102-TP-B13)
This publication has 68 references indexed in Scilit:
- Mechanism of cell death resulting from DNA interstrand cross-linking in mammalian cellsCell Death & Disease, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 AntibodyClinical Cancer Research, 2009
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant MetastasisCancer Cell, 2009
- Modes of resistance to anti-angiogenic therapyNature Reviews Cancer, 2008
- Novel cytotoxic drugs: Old challenges, new solutionsCancer Treatment Reviews, 2008
- Rapid vascular regrowth in tumors after reversal of VEGF inhibitionJournal of Clinical Investigation, 2006
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- Genentech discloses safety concerns over AvastinNature Biotechnology, 2004
- “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein AAnalytical Biochemistry, 1981